Back to User profile » Dr Mark Jaros
Papers published by Dr Mark Jaros:
Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials
Wirta DL, Korenfeld MS, Foster S, Smyth-Medina R, Bacharach J, Kannarr SR, Jaros MJ, Slonim CB
Clinical Ophthalmology 2021, 15:4035-4048
Published Date: 8 October 2021
Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results
Bacharach J, Wirta DL, Smyth-Medina R, Korenfeld MS, Kannarr SR, Foster S, Jaros MJ, Slonim CB
Clinical Ophthalmology 2021, 15:2743-2751
Published Date: 25 June 2021
A randomized, multicenter, pilot study comparing the efficacy and safety of a bupivacaine-collagen implant (XaraColl®) with the ON-Q PainBuster® Post-op Pain Relief System following open gynecological surgery
Cusack SL, Minkowitz HS, Kuss M, Jaros M, Hemsen L
Journal of Pain Research 2012, 5:453-461
Published Date: 2 November 2012
Clinical evaluation of XaraColl®, a bupivacaine-collagen implant, for postoperative analgesia in two multicenter, randomized, double-blind, placebo-controlled pilot studies
Cusack SL, Jaros M, Kuss M, Minkowitz HS, Winkle P, Hemsen L
Journal of Pain Research 2012, 5:217-225
Published Date: 27 June 2012